Triangle CROs see opportunity, challenges in push for diversity in clinical trials


The FDA's push to improve diversity among clinical trial participants could create new opportunities for Triangle contract research organizations.

Previous CEO of Charlotte-based cbdMD steps down as chairman in wake of SEC fraud allegations
Next Bonnie Brae Tavern closing after 88 years, sold to developers